Position in NVS
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$766,830
+$22,174 QoQ
Shares Held
4,893
+0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#713
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JFS WEALTH ADVISORS, LLC holds $17,102,053 across 16 Drug Manufacturers - General names. NVS ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
30,534 | $7,754,719 | |
| 2 | ABBV |
AbbVie Inc.
|
10,506 | $2,643,729 | |
| 3 | MRK |
Merck & Co., Inc.
|
18,599 | $2,389,971 | |
| 4 | LLY |
ELI LILLY & Co
|
901 | $1,080,686 | |
| 5 | PFE |
Pfizer Inc
|
40,840 | $983,427 | |
| 6 | NVS |
Novartis AG
This page
|
4,893 | $766,830 | |
| 7 | AZN |
Astrazeneca PLC
|
2,497 | $473,481 | |
| 8 | AMGN |
Amgen Inc
|
1,004 | $363,568 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $766,830 | 4,893 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $744,656 | 4,875 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $678,596 | 4,922 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $631,197 | 4,922 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $611,584 | 5,054 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $567,098 | 5,087 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $477,694 | 4,909 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $576,595 | 5,013 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $208,555 | 1,959 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $187,752 | 1,941 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $207,089 | 2,051 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $209,322 | 2,055 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $127,146 | 1,260 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $123,924 | 1,347 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $128,278 | 1,414 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $183,868 | 2,419 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $196,025 | 2,319 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $228,413 | 2,603 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $255,149 | 2,917 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $244,603 | 2,991 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $172,534 | 1,891 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $149,760 | 1,752 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $129,085 | 1,367 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $59,132 | 680 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $59,391 | 680 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $56,066 | 680 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||